EquityFlow
›
Companies
› ViaNautis
ViaNautis
Biotech
· Cambridge, GB
Nanomedicine company developing the polyNaut drug-delivery platform (formerly SomaServe).
Funding history
Date
Round
Amount
Nov 2023
Series A
UK nanomedicine company ViaNautis raised a $25M Series A led by 4BIO Capital for its polyNaut drug-delivery platform.
$25M
Investors
4BIO Capital
BGF
UCB Ventures
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →